tirzepatide sglt2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Effects of tirzepatide, a dual

Semaglutide is used in Wegovy and Ozempic

97 , E1023E1031 (2012)

According to the FDA prescribing information for Zepbound, in the SURMOUNT-1 trial, cholelithiasis was reported in 2.5% of patients receiving tirzepatide compared to 1.0% of patients on placebo

Benefits of Tirzepatide for Weight Loss Based on clinical trials, patients using Tirzepatide may experience: Substantial A1C reductions Increased weight loss Improvements in cardiometabolic measures Improved triglycerides levels Reduced appetite Decreased blood pressure Improved insulin sensitivity Conclusion Tirzepatide had an overall safety and tolerability profile, similar to other therapies approved for the treatment of obesity

Reading a 1 mL (100-unit) syringe A 1 mL insulin syringe has major markings at every 10 units (10, 20, 30, and so on up to 100)

For pancreatitis from other causes, individualized medical advice is needed, but extreme caution with alcohol is warranted given the potential association between GLP-1 receptor agonists and pancreatitis risk